Avion Wealth’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2K Hold
62
﹤0.01% 1134
2026
Q1
$1K Hold
62
﹤0.01% 1159
2025
Q4
$1K Hold
62
﹤0.01% 1146
2025
Q3
$0 Hold
62
﹤0.01% 1557
2025
Q2
$0 Buy
+62
New +$565 ﹤0.01% 1617
2024
Q4
Sell
-69
Closed -$1K 1282
2024
Q3
$1K Buy
69
+47
+214% +$972 ﹤0.01% 916
2024
Q2
$0 Buy
+22
New +$576 ﹤0.01% 1255
2024
Q1
Sell
-25
Closed -$1K 1225
2023
Q4
$1K Buy
+25
New +$1.09K ﹤0.01% 992

Other funds holding TXG

Avion Wealth's TXG Position: Q2 2026 in Review

Avion Wealth held its 10x Genomics (TXG) position steady in Q2 2026 at 62 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1134.

Avion Wealth first reported a position in TXG in Q4 2023 and has held it in 8 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Avion Wealth held 62 shares of 10x Genomics worth $2K as of Q2 2026.
  • Avion Wealth left its 10x Genomics share count unchanged in Q2 2026.
  • 10x Genomics made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #1134 holding.
  • Avion Wealth first reported a position in 10x Genomics in Q4 2023 and has held it in 8 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.